1|Page
NRNP 6552 MODULES 1-3 KNOWLEDGE CHECK:
220+ HIGH-YIELD QUESTIONS & ANSWERS
WITH RATIONALES (2026-2027 UPDATE) –
ADVANCED CARE OF WOMEN & NEONATES
## Table of Contents
| Module | Topic Area | Question Numbers |
|--------|------------|------------------|
| **Module 1** | Foundations of Women’s Health & Gynecologic Care |
1–100 |
| 1.1 | Health Maintenance & Screening Guidelines | 1–25 |
| 1.2 | Pharmacology & Contraception | 26–60 |
| 1.3 | Common Gynecologic Conditions | 61–100 |
| **Module 2** | Antepartum Care & Complications | 101–160 |
| 2.1 | Prenatal Care & Physiologic Changes | 101–130 |
| 2.2 | Common Antepartum Complications | 131–160 |
| **Module 3** | Intrapartum, Postpartum, & Neonatal Care | 161–220 |
| 3.1 | Intrapartum & Fetal Monitoring | 161–185 |
| 3.2 | Postpartum Complications | 186–205 |
| 3.3 | Newborn & Neonatal High-Yield Topics | 206–220 |
,2|Page
---
# MODULE 1: FOUNDATIONS OF WOMEN’S HEALTH &
GYNECOLOGIC CARE
## 1.1 Health Maintenance & Screening Guidelines (Questions 1–25)
**1. A 23-year-old woman presents for an annual exam. According to
USPSTF 2026 guidelines, which screening is NOT routinely
recommended?**
A. Chlamydia screening if sexually active
B. Cervical cancer screening with Pap
C. Lipid panel screening
D. Blood pressure screening
**Answer: C**
*Rationale:* USPSTF recommends lipid screening starting at age 40–
75; not routinely in low-risk 23-year-olds. Pap starts at 21. Chlamydia
screen annually if sexually active <25. BP screen annually.
**2. What is the USPSTF grade for routine mammography screening in
average-risk women aged 50–74?**
A. Grade A
,3|Page
B. Grade B
C. Grade C
D. Grade D
**Answer: B**
*Rationale:* USPSTF Grade B (recommended) for mammography q2
years in 50–74. Grade C for 40–49 (individualized decision).
**3. At what age should cervical cancer screening begin for average-risk
women per ASCCP/ACOG?**
A. 18
B. 21
C. 25
D. 30
**Answer: B**
*Rationale:* Screening starts at 21 regardless of sexual activity onset.
Co-testing with HPV begins at 30.
**4. A 30-year-old woman with negative Pap and negative HPV has
normal co-testing. When is next screening due?**
A. 1 year
B. 3 years
, 4|Page
C. 5 years
D. 10 years
**Answer: C**
*Rationale:* Co-testing (Pap+HPV) negative q5 years for 30–65. Pap
alone q3 years.
**5. Which patient requires referral for hereditary breast and ovarian
cancer (HBOC) genetic counseling?**
A. 45-year-old with breast cancer, no family history
B. 35-year-old with ovarian cancer
C. 50-year-old with Ashkenazi Jewish ancestry, no cancer
D. 28-year-old with fibroadenoma
**Answer: B**
*Rationale:* Ovarian cancer at any age, breast cancer ≤45, multiple
family members with BRCA-related cancers, or Ashkenazi Jewish with
breast/ovarian cancer.
**6. USPSTF recommends osteoporosis screening starting at age:**
A. 50
B. 55
C. 60
NRNP 6552 MODULES 1-3 KNOWLEDGE CHECK:
220+ HIGH-YIELD QUESTIONS & ANSWERS
WITH RATIONALES (2026-2027 UPDATE) –
ADVANCED CARE OF WOMEN & NEONATES
## Table of Contents
| Module | Topic Area | Question Numbers |
|--------|------------|------------------|
| **Module 1** | Foundations of Women’s Health & Gynecologic Care |
1–100 |
| 1.1 | Health Maintenance & Screening Guidelines | 1–25 |
| 1.2 | Pharmacology & Contraception | 26–60 |
| 1.3 | Common Gynecologic Conditions | 61–100 |
| **Module 2** | Antepartum Care & Complications | 101–160 |
| 2.1 | Prenatal Care & Physiologic Changes | 101–130 |
| 2.2 | Common Antepartum Complications | 131–160 |
| **Module 3** | Intrapartum, Postpartum, & Neonatal Care | 161–220 |
| 3.1 | Intrapartum & Fetal Monitoring | 161–185 |
| 3.2 | Postpartum Complications | 186–205 |
| 3.3 | Newborn & Neonatal High-Yield Topics | 206–220 |
,2|Page
---
# MODULE 1: FOUNDATIONS OF WOMEN’S HEALTH &
GYNECOLOGIC CARE
## 1.1 Health Maintenance & Screening Guidelines (Questions 1–25)
**1. A 23-year-old woman presents for an annual exam. According to
USPSTF 2026 guidelines, which screening is NOT routinely
recommended?**
A. Chlamydia screening if sexually active
B. Cervical cancer screening with Pap
C. Lipid panel screening
D. Blood pressure screening
**Answer: C**
*Rationale:* USPSTF recommends lipid screening starting at age 40–
75; not routinely in low-risk 23-year-olds. Pap starts at 21. Chlamydia
screen annually if sexually active <25. BP screen annually.
**2. What is the USPSTF grade for routine mammography screening in
average-risk women aged 50–74?**
A. Grade A
,3|Page
B. Grade B
C. Grade C
D. Grade D
**Answer: B**
*Rationale:* USPSTF Grade B (recommended) for mammography q2
years in 50–74. Grade C for 40–49 (individualized decision).
**3. At what age should cervical cancer screening begin for average-risk
women per ASCCP/ACOG?**
A. 18
B. 21
C. 25
D. 30
**Answer: B**
*Rationale:* Screening starts at 21 regardless of sexual activity onset.
Co-testing with HPV begins at 30.
**4. A 30-year-old woman with negative Pap and negative HPV has
normal co-testing. When is next screening due?**
A. 1 year
B. 3 years
, 4|Page
C. 5 years
D. 10 years
**Answer: C**
*Rationale:* Co-testing (Pap+HPV) negative q5 years for 30–65. Pap
alone q3 years.
**5. Which patient requires referral for hereditary breast and ovarian
cancer (HBOC) genetic counseling?**
A. 45-year-old with breast cancer, no family history
B. 35-year-old with ovarian cancer
C. 50-year-old with Ashkenazi Jewish ancestry, no cancer
D. 28-year-old with fibroadenoma
**Answer: B**
*Rationale:* Ovarian cancer at any age, breast cancer ≤45, multiple
family members with BRCA-related cancers, or Ashkenazi Jewish with
breast/ovarian cancer.
**6. USPSTF recommends osteoporosis screening starting at age:**
A. 50
B. 55
C. 60
